Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. Tata Motors appointed Tim Leverthon, who previously led R&D at BMW, as head of its global R&D. and the U.K.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Skip Prichard

JULY 22, 2019

In fact, his inventions in three-phase electric power and alternating current eventually enabled the global distribution of electricity as we know it. Tesla’s genius and education led him to develop the foundations for electric induction motors, wireless telegraphy, radios, neon lamps, and remote control. and we like to stick to our knitting.

Innovation 80

Innovation Social Capital Reputation How To 80

Harvard Business Review

JUNE 21, 2013

Given the forecasts of uncertain global economic growth, we might expect companies to hold off from hiring new employees and to limit whatever international hiring they do to emerging markets. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Global business Talent management'

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. Prescient VCs may make global investments in low-cost, high-volume specialty hospitals to complement their R&D start-ups.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

FEBRUARY 22, 2017

Directors acknowledge cybersecurity as an urgent global issue, but are failing to make the connection between the pervasiveness of cyberthreats and their companies’ vulnerabilities. Why the disconnect between the global- and company-level views? banking & financial services, insurance, real estate); Healthcare (e.g.,

Telecommunications 8

Telecommunications Health Care Contingency Plans Biotechnology 8

Harvard Business Review

FEBRUARY 16, 2016

Leading the list are the economy; the regulatory environment; and cybersecurity, according to our global survey of over 4,000 corporate directors, conducted in partnership with WomenCorporateDirectors Foundation, led by Susan Stautberg, Spencer Stuart, led by Julie Hembrock Daum, and independent researcher Deborah Bell. With the 2016 U.S.

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

OCTOBER 1, 2014

In the coming eight weeks, we are engaging in a global effort to focus more of the entrepreneurship conversation on scale-ups and their positive impacts on societies and economies. New company starts are easier to count, but they alone don’t have the positive impact on economies that growing a company does.

Entrepreneur 11

Entrepreneur Biotechnology Real Estate Innovation 11

Harvard Business Review

OCTOBER 26, 2011

Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Click on the table below to see at full size.).

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

SEPTEMBER 21, 2018

Between January and June 2016, we worked with Harvard Business School’s Global Research Centers to increase the response rate outside of the United States. The industry breakdowns were determined using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g.,

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

NOVEMBER 15, 2016

This post is one in a series of perspectives by presenters and participants in the 8th Global Drucker Forum. In contrast, New England has increasingly become a hub for ventures in life sciences; the first three-quarters of 2016 saw almost 60% of VC investments in New England go to ventures in biotechnology and medical devices.

Biotechnology 8

Biotechnology Drucker Software Entrepreneur 8

Strategy Driven

NOVEMBER 18, 2019

Globally, the energy sector is valued in excess of $7 trillion and by 2035 it is anticipated that the global demand for energy will increase by as much as 30%. There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in.

Health Care 67

Health Care Biotechnology Energy Insurance 67

Harvard Business Review

MARCH 11, 2014

Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants). Finally, certain problems are almost custom-made for global giants. The inspiring idea had clear potential to make a global impact.

Innovation 8

Innovation Venture Capitalist Company Supply Chain 8

Harvard Business Review

JULY 16, 2013

And 43% cited technology expertise, HR-talent management, international-global expertise, and succession planning as the skills missing most on their boards. The industry with the greatest skills gap was IT & telecommunications, whose boards are in serious need of international-global expertise and HR-talent management.

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

JUNE 3, 2013

The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., banking & financial services, insurance, real estate); Health Care (e.g.,

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

JANUARY 5, 2012

For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. These technologies improve productivity and facilitate better living standards when they penetrate into societies.

Information Technology 15

Information Technology Technology Information Trends 15

Harvard Business Review

MARCH 13, 2012

Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa? Wouldn't it make sense to test drive state-owned banks elsewhere to see if they could help support local industries? Our 50 states have been called laboratories of democracy.

Biotechnology 10

Biotechnology Real Estate Tourism Banking 10

Harvard Business Review

MAY 10, 2016

Our experience with many global companies across industries and sectors has revealed a framework for pursuing growth through acquisition that lowers risks and helps beat the odds. Often the weakest assumptions involve estimates of how much additional revenue the companies can generate when combined. This, in turn, leads bidders to overpay.

Strategy 8

Strategy Company Biotechnology Franchising 8

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. The positions are there for the taking. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 1, 2012

That imbalance represents a huge missed opportunity for the United States in its attempts to regain global competitiveness. For example, in biotechnology, a field in which the U.S. They're in Singapore, South Korea, Taiwan, Ireland, and even Switzerland. CMOs do a lot of good.

Contract Manufacturing 9

Contract Manufacturing Offshoring Supply Chain Biotechnology 9

Harvard Business Review

OCTOBER 22, 2013

When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. During the initial phases of our work together, it becomes obvious that they have plenty of good ideas.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

JUNE 16, 2016

Giulio Draetta , the Director of IACS who formerly headed up global basic research at Merck, points out that for academic researchers, publication is the coin of the realm, so they are focused on uncovering results that are new and exciting, not on marketability. .”

Technology 8

Technology Venture Capitalist Supply Chain Innovation 8

Harvard Business Review

FEBRUARY 3, 2015

For example, recently we were in a meeting discussing the results of a global people survey. Uzzi and another colleague, Jarrett Spiro, also discovered that this pattern held across sectors as disparate as the Broadway mu­sical industry and biotechnology.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

MAY 28, 2013

In one of the most comprehensive global surveys of corporate directors to date, we found that they were very worried about developing and enacting strategic plans that will enable their organizations to succeed. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., Not rising costs.

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

NOVEMBER 29, 2016

It has been aggressively recruiting and developing people with the requisite skills, partnering with universities and firms such as The Data Incubator to recruit and train data scientists, and it now has an entrepreneurial global team of more than 80.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MARCH 17, 2014

An estimated 250 funds are actively raising capital in a market that the Global Impact Investing Network estimates at $25 billion. In impact investing, we need to find a way to place that same premium on social impact by valuing the public good being created – just like we do in early stage R&D in science, IT, health, and biotechnology.

Development 9

Development Microfinance Biotechnology Exit Strategy 9

Harvard Business Review

JUNE 23, 2015

Exciting applications have already been demonstrated across all sectors — from aerospace and medical applications to biotechnology and food production.

Supply Chain 8

Supply Chain Tacit Knowledge Contract Manufacturing Biotechnology 8

Harvard Business Review

JANUARY 11, 2017

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. In late 2001 ImClone awaited approval from the Food and Drug Administration (FDA) of its much-heralded new cancer treatment, but unexpectedly the FDA decided to reject the company’s application.

Ethics 8

Ethics Training Biotechnology Morale 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. Eric Haller, EVP and Global Head at Experian Data Labs emphasizes creating a culture of discovery. vincent tsui FOR HBR. Since World War II, the U.S.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JULY 22, 2015

” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. The chairman, Jae Kyung Park, was often quoted as saying that he wanted Hanguk to be a symbol of progress in Korea, with best practices that matched those of its global competitors.

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. A decade from now we may look back at China's 12th Five-Year Plan as the seminal document of the early 21st century. It pledges $1.5

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

NOVEMBER 9, 2016

The conventional understanding of policy makers and academics is that the way forward for developing countries is to integrate into global value chains, mostly by carrying out low-value activities. That’s how they climb the global value chain. For Mexico, I suggest you watch the avocado industry.

Cooper 14

Cooper Long-term Industry Health Care 14

Harvard Business Review

AUGUST 23, 2016

Democrats are less pessimistic about the economy: 10% of Democrats expect a global economic slowdown in the next three years, compared to 18% of Republicans. The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g.,

Politics 8

Politics Committee Telecommunications Diversity 8